Patient Files: prostate cancer
Chris James shares his experiences with different treatments for testicular and prostate cancer
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
SmartPeople: James Merson
James Merson, global therapeutic area head for Infectious Diseases at Janssen Research & Development, believes that through continued advancements in science “we can change the trajectory of health for humanity and strive to make infectious diseases an issue of the past”
Pharmaceutical pricing - it’s political
Dr Joe Zammit-Lucia on why it is becoming increasingly import for pharma companies to develop new approaches to pricing that have political resonance
Company Focus: MedPharm
Jeremy Drummond, senior vice president of Business Development at MedPharm, on the challenges and opportunities of topical delivery
Connected labelling - the final frontier?
However much progress life sciences companies have made in bringing their regulatory information under control, labelling management continues to overshadow these accomplishments. Too often labelling is disconnected from other systems, forcing heavy reliance on manual processes and checks which in turn can cause hold-ups and create an undesirable source of risk, especially across country borders. Agnes Cwienczek delves deeper into the issues and potential remedies
The modern marketing maze
Marketing in our industry is not for the faint-hearted, although it is an area where dynamic teams can discover communicative muscles they never knew they had. As digital possibilities emerge at pace, the modern marketing maze offers exciting opportunities, but identifying them amid regulation and digital domination presents a formidable set of challenges. Challenges which, curiously, many relish...
The promised land?
Brexit was supposed to be an opportunity for the UK to strike trade deals outside the EU, but the going is tough
A true partnership
Michael Goetzl says it’s time for industry to work in true partnership with health systems “at every step of the way” to speed up access to innovation
